The Mitochondrion: A Promising Target for Kidney Disease

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2023 Feb 25

PMID 36839892

Authors

Cem Tanriover

Sidar Copur

Duygu Ucku

Ahmet B Cakir

Nuri B Hasbal

Maria Jose Soler

Mehmet Kanbay

Affiliations

Soon will be listed here.

Abstract

Mitochondrial dysfunction is important in the pathogenesis of various kidney diseases and the mitochondria potentially serve as therapeutic targets necessitating further investigation. Alterations in mitochondrial biogenesis, imbalance between fusion and fission processes leading to mitochondrial fragmentation, oxidative stress, release of cytochrome c and mitochondrial DNA resulting in apoptosis, mitophagy, and defects in energy metabolism are the key pathophysiological mechanisms underlying the role of mitochondrial dysfunction in kidney diseases. Currently, various strategies target the mitochondria to improve kidney function and kidney treatment. The agents used in these strategies can be classified as biogenesis activators, fission inhibitors, antioxidants, mPTP inhibitors, and agents which enhance mitophagy and cardiolipin-protective drugs. Several glucose-lowering drugs, such as glucagon-like peptide-1 receptor agonists (GLP-1-RA) and sodium glucose co-transporter-2 (SGLT-2) inhibitors are also known to have influences on these mechanisms. In this review, we delineate the role of mitochondrial dysfunction in kidney disease, the current mitochondria-targeting treatment options affecting the kidneys and the future role of mitochondria in kidney pathology.

Citing Articles

Slc25a21 in cisplatin-induced acute kidney injury: a new target for renal tubular epithelial protection by regulating mitochondrial metabolic homeostasis.

Su X, Bai M, Shang Y, Du Y, Xu S, Lin X Cell Death Dis. 2024; 15(12):891.

PMID: 39695098 PMC: 11655545. DOI: 10.1038/s41419-024-07231-2.

A Focus on the Proximal Tubule Dysfunction in Dent Disease Type 1.

de Combiens E, Sakhi I, Lourdel S Genes (Basel). 2024; 15(9).

PMID: 39336766 PMC: 11431675. DOI: 10.3390/genes15091175.

Mitochondrial dysfunction in acute kidney injury.

Yao C, Li Z, Sun K, Zhang Y, Shou S, Jin H Ren Fail. 2024; 46(2):2393262.

PMID: 39192578 PMC: 11360640. DOI: 10.1080/0886022X.2024.2393262.

Sirtuins in kidney diseases: potential mechanism and therapeutic targets.

Jin Q, Ma F, Liu T, Yang L, Mao H, Wang Y Cell Commun Signal. 2024; 22(1):114.

PMID: 38347622 PMC: 10860260. DOI: 10.1186/s12964-023-01442-4.

Effects of Microplastic (MP) Exposure at Environmentally Relevant Doses on the Structure, Function, and Transcriptome of the Kidney in Mice.

Shen T, Zhang W, Wang Y, Li H, Wu J, Wang Q Molecules. 2023; 28(20).

PMID: 37894583 PMC: 10608837. DOI: 10.3390/molecules28207104.

References

Bhatia D, Chung K, Nakahira K, Patino E, Rice M, Torres L . Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis. JCI Insight. 2019; 4(23). PMC: 6962025. DOI: 10.1172/jci.insight.132826. View

Ryu D, Mouchiroud L, Andreux P, Katsyuba E, Moullan N, Nicolet-Dit-Felix A . Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med. 2016; 22(8):879-88. DOI: 10.1038/nm.4132. View

Lee J, Westrate L, Wu H, Page C, Voeltz G . Multiple dynamin family members collaborate to drive mitochondrial division. Nature. 2016; 540(7631):139-143. PMC: 5656044. DOI: 10.1038/nature20555. View

Yang S, Li A, Han Y, Peng C, Song N, Yang M . Mitochondria-Targeted Peptide SS31 Attenuates Renal Tubulointerstitial Injury via Inhibiting Mitochondrial Fission in Diabetic Mice. Oxid Med Cell Longev. 2019; 2019:2346580. PMC: 6589270. DOI: 10.1155/2019/2346580. View

Bell E, Klimova T, Eisenbart J, Schumacker P, Chandel N . Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. Mol Cell Biol. 2007; 27(16):5737-45. PMC: 1952129. DOI: 10.1128/MCB.02265-06. View

Tagaya M, Kume S, Yasuda-Yamahara M, Kuwagata S, Yamahara K, Takeda N . Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease. Biochim Biophys Acta Mol Basis Dis. 2022; 1868(5):166368. DOI: 10.1016/j.bbadis.2022.166368. View

Mikhailov V, Mikhailova M, Degenhardt K, Venkatachalam M, White E, Saikumar P . Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome c release. J Biol Chem. 2002; 278(7):5367-76. DOI: 10.1074/jbc.M203392200. View

Jain M, Rivera S, Monclus E, Synenki L, Zirk A, Eisenbart J . Mitochondrial reactive oxygen species regulate transforming growth factor-β signaling. J Biol Chem. 2012; 288(2):770-7. PMC: 3543026. DOI: 10.1074/jbc.M112.431973. View

Yang H, Ma L, Ma J, Fogo A . Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis. Kidney Int. 2006; 69(10):1756-64. DOI: 10.1038/sj.ki.5000336. View

10.

Xiao L, Xu X, Zhang F, Wang M, Xu Y, Tang D . The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1. Redox Biol. 2016; 11:297-311. PMC: 5196243. DOI: 10.1016/j.redox.2016.12.022. View

11.

Eirin A, Ebrahimi B, Zhang X, Zhu X, Woollard J, He Q . Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease. Cardiovasc Res. 2014; 103(4):461-72. PMC: 4155472. DOI: 10.1093/cvr/cvu157. View

12.

Kim S, Eirin A, Zhang X, Lerman A, Lerman L . Mitochondrial Protection Partly Mitigates Kidney Cellular Senescence in Swine Atherosclerotic Renal Artery Stenosis. Cell Physiol Biochem. 2019; 52(3):617-632. PMC: 6519989. DOI: 10.33594/000000044. View

13.

Wei Q, Dong G, Chen J, Ramesh G, Dong Z . Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule-specific knockout mouse models. Kidney Int. 2013; 84(1):138-48. PMC: 3686831. DOI: 10.1038/ki.2013.68. View

14.

Li S, Lin Q, Shao X, Zhu X, Wu J, Wu B . Drp1-regulated PARK2-dependent mitophagy protects against renal fibrosis in unilateral ureteral obstruction. Free Radic Biol Med. 2019; 152:632-649. DOI: 10.1016/j.freeradbiomed.2019.12.005. View

15.

Gegg M, Cooper J, Chau K, Rojo M, Schapira A, Taanman J . Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet. 2010; 19(24):4861-70. PMC: 3583518. DOI: 10.1093/hmg/ddq419. View

16.

Chen K, Hsu H, Lee C, Yen T, Ko Y, Yang C . The AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblasts. PLoS One. 2014; 9(9):e106554. PMC: 4154690. DOI: 10.1371/journal.pone.0106554. View

17.

Hondares E, Mora O, Yubero P, Rodriguez de la Concepcion M, Iglesias R, Giralt M . Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma.... Endocrinology. 2006; 147(6):2829-38. DOI: 10.1210/en.2006-0070. View

18.

Sumida M, Doi K, Ogasawara E, Yamashita T, Hamasaki Y, Kariya T . Regulation of Mitochondrial Dynamics by Dynamin-Related Protein-1 in Acute Cardiorenal Syndrome. J Am Soc Nephrol. 2015; 26(10):2378-87. PMC: 4587696. DOI: 10.1681/ASN.2014080750. View

19.

Lee S, Kang J, Kim D, Park S, Jeong H, Lee Y . PGC1 Activators Mitigate Diabetic Tubulopathy by Improving Mitochondrial Dynamics and Quality Control. J Diabetes Res. 2017; 2017:6483572. PMC: 5376939. DOI: 10.1155/2017/6483572. View

20.

Singh S, Tao S, Fields T, Webb S, Harris R, Rao R . Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice. Dis Model Mech. 2015; 8(8):931-40. PMC: 4527294. DOI: 10.1242/dmm.020511. View